What type of study is this?

This is a In Vitro Study study (also classified as: In Vivo Study).

PEG-400 Nanoencapsulated Gotu Kola Leaf Extracts as an Alternative Treatment for Cognitive System Impairment: In-Vitro and In-Vivo Assays

View Full Paper

Ask AI

Bookmark

Authors

In vivo analysis improves cognitive performance in mice, suggesting PEG-400 enhances bioavailability and blood-brain barrier penetration.

The PEG-400 nanoencapsulated formulation reduced maze completion time by 1.44 seconds and TNF-α levels by 19.9%.
Nanoparticle characterization showed 5-7 nm spherical particles with excellent blood-brain barrier penetration potential.
Ellman’s assay confirmed 100% acetylcholinesterase inhibition for key formulations, highlighting neuroprotective effects.
Findings support the potential of Gotu Kola extracts in treating cognitive decline with implications for elderly care.

Limantoro et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

In vivo analysis improves cognitive performance in mice, suggesting PEG-400 enhances bioavailability and blood-brain barrier penetration.

The PEG-400 nanoencapsulated formulation reduced maze completion time by 1.44 seconds and TNF-α levels by 19.9%.
Nanoparticle characterization showed 5-7 nm spherical particles with excellent blood-brain barrier penetration potential.
Ellman’s assay confirmed 100% acetylcholinesterase inhibition for key formulations, highlighting neuroprotective effects.
Findings support the potential of Gotu Kola extracts in treating cognitive decline with implications for elderly care.

Limantoro et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark